Genomic, Clinical, and Behavioral Characterization of 15q11.2 BP1-BP2 Deletion (Burnside-Butler) Syndrome in Five Families

The 15q11.2 BP1-BP2 deletion (Burnside-Butler) syndrome is emerging as the most common cytogenetic finding in patients with neurodevelopmental or autism spectrum disorders (ASD) presenting for microarray genetic testing. Clinical findings in Burnside-Butler syndrome include developmental and motor delays, congenital abnormalities, learning and behavioral problems, and abnormal brain findings. To better define symptom presentation, we performed comprehensive cognitive and behavioral testing, collected medical and family histories, and conducted clinical genetic evaluations. The 15q11.2 BP1-BP2 region includes the TUBGCP5, CYFIP1, NIPA1, and NIPA2 genes. To determine if additional genomic variation outside of the 15q11.2 region influences expression of symptoms in Burnside-Butler syndrome, whole-exome sequencing was performed on the parents and affected children for the first time in five families with at least one parent and child with the 15q1l.2 BP1-BP2 deletion. In total, there were 453 genes with possibly damaging variants identified across all of the affected children. Of these, 99 genes had exclusively de novo variants and 107 had variants inherited exclusively from the parent without the deletion. There were three genes (APBB1, GOLGA2, and MEOX1) with de novo variants that encode proteins evidenced to interact with CYFIP1. In addition, one other gene of interest (FAT3) had variants inherited from the parent without the deletion and encoded a protein interacting with CYFIP1. The affected individuals commonly displayed a neurodevelopmental phenotype including ASD, speech delay, abnormal reflexes, and coordination issues along with craniofacial findings and orthopedic-related connective tissue problems. Of the 453 genes with variants, 35 were associated with ASD. On average, each affected child had variants in 6 distinct ASD-associated genes (x¯ = 6.33, sd = 3.01). In addition, 32 genes with variants were included on clinical testing panels from Clinical Laboratory Improvement Amendments (CLIA) approved and accredited commercial laboratories reflecting other observed phenotypes. Notably, the dataset analyzed in this study was small and reported results will require validation in larger samples as well as functional follow-up. Regardless, we anticipate that results from our study will inform future research into the genetic factors influencing diverse symptoms in patients with Burnside-Butler syndrome, an emerging disorder with a neurodevelopmental behavioral phenotype.

[1]  M. Butler,et al.  The 15q11.2 BP1-BP2 Microdeletion (Burnside–Butler) Syndrome: In Silico Analyses of the Four Coding Genes Reveal Functional Associations with Neurodevelopmental Disorders , 2020, International journal of molecular sciences.

[2]  Z. Warren,et al.  Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2016 , 2020, Morbidity and mortality weekly report. Surveillance summaries.

[3]  Guan Ning Lin,et al.  De novo Mutations From Whole Exome Sequencing in Neurodevelopmental and Psychiatric Disorders: From Discovery to Application , 2019, Front. Genet..

[4]  B. Dallapiccola,et al.  Parent-of-Origin Effects in 15q11.2 BP1-BP2 Microdeletion (Burnside-Butler) Syndrome , 2019, International journal of molecular sciences.

[5]  S. Lui,et al.  Static and dynamic postural control deficits in aging fragile X mental retardation 1 (FMR1) gene premutation carriers , 2019, Journal of Neurodevelopmental Disorders.

[6]  C. Ross,et al.  A de novo mosaic mutation in SPAST with two novel alternative alleles and chromosomal copy number variant in a boy with spastic paraplegia and autism spectrum disorder. , 2017, European journal of medical genetics.

[7]  M. Butler,et al.  Clinical and genetic aspects of the 15q11.2 BP1–BP2 microdeletion disorder , 2017, Journal of intellectual disability research : JIDR.

[8]  Sonya Girdler,et al.  Standing Postural Control in Individuals with Autism Spectrum Disorder: Systematic Review and Meta-analysis , 2017, Journal of autism and developmental disorders.

[9]  Qianqian Pang,et al.  Loss of the golgin GM130 causes Golgi disruption, Purkinje neuron loss, and ataxia in mice , 2016, Proceedings of the National Academy of Sciences.

[10]  A. Prasad,et al.  Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders , 2016, International journal of molecular sciences.

[11]  J. Sweeney,et al.  Postural orientation and equilibrium processes associated with increased postural sway in autism spectrum disorder (ASD) , 2016, Journal of Neurodevelopmental Disorders.

[12]  D. Delis,et al.  The California verbal learning test , 2016 .

[13]  M. Butler,et al.  Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches. , 2016, Current pediatric reviews.

[14]  F. Cunningham,et al.  The Ensembl Variant Effect Predictor , 2016, bioRxiv.

[15]  M. Butler,et al.  The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review , 2015, International journal of molecular sciences.

[16]  Andreas Krämer,et al.  Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..

[17]  Mauricio O. Carneiro,et al.  From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.

[18]  U. Hansen,et al.  The expanded collagen VI family: new chains and new questions , 2013, Connective tissue research.

[19]  J. Piven,et al.  The Broad Autism Phenotype Questionnaire: Prevalence and Diagnostic Classification , 2013, Autism research : official journal of the International Society for Autism Research.

[20]  I. Adzhubei,et al.  Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2 , 2013, Current protocols in human genetics.

[21]  C. Lord,et al.  Patterns of developmental trajectories in toddlers with autism spectrum disorder. , 2012, Journal of consulting and clinical psychology.

[22]  Pablo Cingolani,et al.  © 2012 Landes Bioscience. Do not distribute. , 2022 .

[23]  D. J. Driscoll,et al.  Methylation-specific multiplex ligation-dependent probe amplification and identification of deletion genetic subtypes in Prader-Willi syndrome. , 2012, Genetic testing and molecular biomarkers.

[24]  S. Schwartz,et al.  Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay , 2011, Human Genetics.

[25]  Jonathan A. Cooper,et al.  Reelin and Stk25 Have Opposing Roles in Neuronal Polarization and Dendritic Golgi Deployment , 2010, Cell.

[26]  Daniel J Driscoll,et al.  Clinical and genetic aspects of Angelman syndrome , 2010, Genetics in Medicine.

[27]  F. Cremers,et al.  CDK19 is disrupted in a female patient with bilateral congenital retinal folds, microcephaly and mild mental retardation , 2010, Human Genetics.

[28]  G. Quamme Molecular identification of ancient and modern mammalian magnesium transporters. , 2010, American journal of physiology. Cell physiology.

[29]  Jonathan M. Campbell,et al.  Peabody Picture Vocabulary Test , 2010 .

[30]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[31]  C. Lord,et al.  Standardizing ADOS Scores for a Measure of Severity in Autism Spectrum Disorders , 2009, Journal of autism and developmental disorders.

[32]  Joseph Piven,et al.  The Broad Autism Phenotype Questionnaire , 2007, Journal of autism and developmental disorders.

[33]  L. Holsen,et al.  The relationship between compulsive behaviour and academic achievement across the three genetic subtypes of Prader-Willi syndrome. , 2007, Journal of intellectual disability research : JIDR.

[34]  P. S. St George-Hyslop,et al.  Clinical and genetic study of a Brazilian family with spastic paraplegia (SPG6 locus) , 2006, Movement disorders : official journal of the Movement Disorder Society.

[35]  K. Hoffmann,et al.  Spastin related hereditary spastic paraplegia with dysplastic corpus callosum , 2005, Journal of the Neurological Sciences.

[36]  M. Butler,et al.  Prader–Willi syndrome: clinical genetics, cytogenetics and molecular biology , 2005, Expert Reviews in Molecular Medicine.

[37]  J. Zarcone,et al.  Maladaptive behaviors and risk factors among the genetic subtypes of Prader–Willi syndrome , 2005, American journal of medical genetics. Part A.

[38]  G. Gundersen,et al.  Linking axonal degeneration to microtubule remodeling by Spastin-mediated microtubule severing , 2005, The Journal of cell biology.

[39]  Z. Talebizadeh,et al.  Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. , 2004, Pediatrics.

[40]  J. Fink,et al.  NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6). , 2003, American journal of human genetics.

[41]  C. Wright,et al.  The concerted action of Meox homeobox genes is required upstream of genetic pathways essential for the formation, patterning and differentiation of somites , 2003, Development.

[42]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[43]  E. Rugarli,et al.  Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics. , 2002, Human molecular genetics.

[44]  M H Lewis,et al.  Varieties of Repetitive Behavior in Autism: Comparisons to Mental Retardation , 2000, Journal of autism and developmental disorders.

[45]  Y. Miki,et al.  Isolation of a diverged homeobox gene, MOX1, from the BRCA1 region on 17q21 by solution hybrid capture. , 1994, Human molecular genetics.

[46]  P. Lachenbruch Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .

[47]  J. Knoll,et al.  Genetic imprinting suggested by maternal heterodisomy in non-deletion Prader-Willi syndrome , 1989, Nature.

[48]  V. A. Holm,et al.  Management of Prader-Willi Syndrome , 1977, The Journal of pediatrics.

[49]  R. Grantham Amino Acid Difference Formula to Help Explain Protein Evolution , 1974, Science.

[50]  Jacob Cohen Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[51]  R. Reitan Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .

[52]  V. Cimolin,et al.  Characterisation of balance capacity in Prader-Willi patients. , 2011, Research in developmental disabilities.

[53]  S. Ricard-Blum The collagen family. , 2011, Cold Spring Harbor perspectives in biology.

[54]  M. Seltzer,et al.  Age-Related Differences in Restricted Repetitive Behaviors in Autism Spectrum Disorders , 2009, Journal of autism and developmental disorders.

[55]  Dennis R. Dixon,et al.  Adaptive Behavior Scales , 2007 .